BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions In 2026, the question "Are peptides legal?" has been answered with a decisive regulatory crackdown. , The FDA has moved beyond general oversight into targeted enforcement. Popular wellness